Fol. Biol. 2009, 55, 77-84
https://doi.org/10.14712/fb2009055030077
Expression Pattern of Dipeptidyl Peptidase IV Activity and/or Structure Homologues in Cancer
References
1. 2000) Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8. Eur. J. Biochem. 267, 6140-6150.
< , C. A., Yu, D. M., Woollatt, E., Sutherland, G. R., McCaughan, G. W., Gorrell, M. D. (https://doi.org/10.1046/j.1432-1327.2000.01617.x>
2. 2004) Dipeptidyl peptidase 9 has two forms, a broad tissue distribution, cytoplasmic localization and DPP-IV like peptidase activity. Biochim. Biophys. Acta 1679, 18-28.
< , K., Abbott, C. A., McCaughan, G. W., Gorrell, M. D. (https://doi.org/10.1016/j.bbaexp.2004.03.010>
3. 2001) Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int. J. Cancer 95, 167-172.
< , N., Sato, E., Ohuchi, N., Nagura, H., Ohtani, H. (https://doi.org/10.1002/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U>
4. 1998) Rat dipeptidyl peptidase IV (DPP IV) exhibits endopeptidase activity with specificity for denatured fibrillar collagens. FEBS Lett. 428, 152-156.
< , F., Loster, K., Reutter, W., Baum, O. (https://doi.org/10.1016/S0014-5793(98)00515-8>
5. 1987) Immunolocalization of dipeptidyl aminopeptidase (DAP IV) in the developing human brain. Int. J. Dev. Neurosci. 5, 237-242.
< , H. G., Schon, E., Ansorge, S., Rose, I., Dorn, A. (https://doi.org/10.1016/0736-5748(87)90034-7>
6. 2004) Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. Int. J. Biochem. Cell Biol. 36, 408-421.
< , P., Malik, R., Sedo, A. (https://doi.org/10.1016/S1357-2725(03)00262-0>
7. 2008) Dipeptidyl peptidase-IV enzymatic activity bearing molecules in human brain tumors – good or evil? Front. Biosci. 1, 2319-2326.
< , P., Stremenova, J., Sedo A. (https://doi.org/10.2741/2846>
8. 1996) Proteases associated with invadopodia, and their role in degradation of extracellular matrix. Enzyme Protein 49, 59-71.
< , W. T. (https://doi.org/10.1159/000468616>
9. 2003) Seprase complexes in cellular invasiveness. Cancer Metastasis Rev. 22, 259-269.
< , W. T., Kelly, T. (https://doi.org/10.1023/A:1023055600919>
10. 1998) Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J. Biol. Chem. 273, 24207-24215.
< , H. C., Abdel-Ghany, M., Elble, R. C., Pauli, B. U. (https://doi.org/10.1074/jbc.273.37.24207>
11. 1999) A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of a post-proline cleaving aminodipeptidase: A candidate target protease, quiescent cell proline dipeptidase. J. Immunol. 163, 3092-3099.
< , M., Schmitz, T., Yardley, K., Underwood, R., Daya, Y., Huber, B. T. (https://doi.org/10.4049/jimmunol.163.6.3092>
12. 2000) Homodimerization via a leucine zipper motif is required for enzymatic activity of quiescent cell proline dipeptidase. J. Biol. Chem. 275, 26994-26999.
< , M., Lee, H., Mathieu, S. L., Huber, B. T. (https://doi.org/10.1016/S0021-9258(19)61470-5>
13. 2005) Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin. Cancer Immun. 5, 10.
, H., Schweifer, N., Puri, C., Kraut, N., Rettig, W.J., Kerjaschki, D., Garin-Chesa, P. (
14. 2006a) Selective inhibition of fibroblast activation protein protease based on dipeptide substrate specificity. J. Biol. Chem. 281, 7437-7444.
< , C. Y., Quan, C., Wiesmann, C., Tran, T., Sutherlin, D., Reynolds, M., Elliott, J. M., Raab, H., Fairbrother, W., Wolf, B. B. (https://doi.org/10.1074/jbc.M511112200>
15. 2006b) Peptide substrate profiling defines fibroblast activation protein as an endopeptidase of strict Gly(2)-Pro(1)-cleaving specificity. FEBS Lett. 580, 1581-1586.
< , C. Y., Quan, C., Tran, T., Pham, V., Wiesmann, C., Fairbrother, W., Wolf, B. B. (https://doi.org/10.1016/j.febslet.2006.01.087>
16. 2003) The crystal structure of dipeptidyl peptidase IV (CD26) reveals its functional regulation and enzymatic mechanism. Proc. Natl. Acad. Sci. USA 100, 5063-5068.
< , M., Hoffmann, T., Wagner, L., Wermann, M., Heiser, U., Kiefersauer, R., Huber, R., Bode, W., Demuth, H. U., Brandstetter, H. (https://doi.org/10.1073/pnas.0230620100>
17. 1999) Regulation of the gene for human dipeptidyl peptidase IV by hepatocyte nuclear factor 1 α. Histochem. J. 338, 91–97.
, R. H., Gum, J. R., Lotterman, C. D., Hicks, J. W., Lai, R. S., Kim, Y. S. (
18. 1994) CD 26: a surface protease involved in Tcell activation. Immunol. Today 15, 180-184.
< , B. (https://doi.org/10.1016/0167-5699(94)90316-6>
19. 1990) Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc. Natl. Acad. Sci. USA 87, 7235-7239.
< , P., Old, L. J., Rettig, W. J. (https://doi.org/10.1073/pnas.87.18.7235>
20. 2002) Regulation of fibroblast migration on collagenous matrix by a cell surface peptidase complex. J. Biol. Chem. 277, 29231-29241.
< , G., Dong, H., Goldstein, L. A., Yeh, Y., Hakkinen, L., Larjava, H. S., Chen, W. T. (https://doi.org/10.1074/jbc.M202770200>
21. 2000) Identification of an alternatively spliced seprase mRNA that encodes a novel intracellular isoform. J. Biol. Chem. 275, 2554-2559.
< , L. A., Chen, W. T. (https://doi.org/10.1074/jbc.275.4.2554>
22. 1997) Molecular cloning of seprase: a serine integral membrane protease from human melanoma. Biochim. Biophys. Acta 1361, 11-19.
< , L. A., Ghersi, G., Piñeiro-Sánchez, M. L., Salamone, M., Yeh, Y., Flessate, D., Chen, W. T. (https://doi.org/10.1016/S0925-4439(97)00032-X>
23. 2001) Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells. Biochem. J. 355, 397-407.
< , M., Grenett, H. E., Weber, M. R., Gawdi, G., Pizzo, S. V. (https://doi.org/10.1042/bj3550397>
24. 2005) Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders. Clin. Sci. 108, 277-292.
< , M. D. (https://doi.org/10.1042/CS20040302>
25. 1998) Direct evidence for the binding of rat liver DPP IV to collagen in vitro. Exp. Cell Res. 178, 64-72.
< , C., Huhle, T., Gossrau, R., Reutter, W. (https://doi.org/10.1016/0014-4827(88)90378-3>
26. 2007) Clinical implications of fibroblast activation protein in patients with colon cancer. Clin. Cancer Res. 13, 1736-1741.
< , L. R., Lee, H. O., Lee, J. S., Klein-Szanto, A., Watts, P., Ross, E. A., Chen, W. T., Cheng, J. D. (https://doi.org/10.1158/1078-0432.CCR-06-1746>
27. 1966) A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie 7, 197-201.
< V. K., Glenner G. G. (https://doi.org/10.1007/BF00577838>
28. 2006) Expression of stromal cell markers in distinct compartments of human skin cancers. J. Cutan. Pathol. 33, 145-155.
< , M. A., Kraut, N., Schweifer, N., Dolznig, H., Peter, R. U., Schubert, R. D., Scharffetter-Kochanek, K., Pehamberger, H., Garin-Chesa, P. (https://doi.org/10.1111/j.0303-6987.2006.00446.x>
29. 2005) Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett. 227, 229-236.
< , S., Okada, K., Chen, W. T., Jin, X., Yamane T., Mitsumata, M. (https://doi.org/10.1016/j.canlet.2004.06.030>
30. 1999) CD26/dipeptidyl peptidase IV in context. The different roles of a multifunctional ectoenzyme in malignant transformation. J. Exp. Med. 190, 301-306.
< , S., Morimoto, C. (https://doi.org/10.1084/jem.190.3.301>
31. 1996a) Dipeptidyl-peptidase IV-β, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity. Eur. J. Biochem. 239, 248-258.
< , E., Callebaut, C., Blanco, J., Krust, B., Neubert, K., Barth, A., Hovanessian, A. G. (https://doi.org/10.1111/j.1432-1033.1996.0248u.x>
32. 1996b) HIV envelope glycoproteininduced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells. Virology 223, 318-330.
< , E., Callebaut, C., Blanco, J., Rivière, Y., Krust, B., Hovanessian, A. G. (https://doi.org/10.1006/viro.1996.0483>
33. 2003) Expression patterns of seprase, a membrane serine protease, in cervical carcinoma and cervical intraepithelial neoplasm. Anticancer Res. 23, 3195-3198.
, X., Iwasa, S., Okada, K., Mitsumata, M., Ooi, A. (
34. 2003) Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases, resulting in decreased invasive potential in ovarian carcinoma cells. Cancer Res. 63, 2278-2283.
, H., Kikkawa, F., Khin, E., Shibata, K., Ino, K., Mizutani, S. (
35. 2003) Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Cancer Res. 63, 8500-8506.
, A., Lendeckel, U., Dralle, H., Langner, J., HoangVu, C. (
36. 2003) Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumour grade. Am. J. Obstet. Gynecol. 188, 670-676.
< , E. E., Kikkawa, F., Ino, K., Kajiyama, H., Suzuki, T., Shibata, K., Tamakoshi, K., Nagasaka, T., Mizutani, S. (https://doi.org/10.1067/mob.2003.169>
37. 2003) Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV. Crit. Rev. Clin. Lab. Sci. 40, 209-294.
< , A. M., Durinx, C., Scharpe, S., De Meester, I. (https://doi.org/10.1080/713609354>
38. 2006) Antiplasmin-cleaving enzyme is a soluble form of fibroblast activation protein. Blood 107, 1397-1404.
< , K. N., Jackson, K. W., Christiansen, V. J., Lee, C. S., Chun, J. G., McKee, P. A. (https://doi.org/10.1182/blood-2005-08-3452>
39. 2003) Catalytic properties and inhibition of prolinespecific dipeptidyl peptidases II, IV and VII. Biochem. J. 371, 525-532.
< , B., Pryor, K. A. D., Wu, J. K., Marsilio, F., Patel, R. A, Craik, C. S., Ellman. J. A., Cummings, R. T, Thornberry, N. A. (https://doi.org/10.1042/bj20021643>
40. 1999) Fibroblast activation protein: A cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology 29, 1768-1778.
< , M. T., McCaughan, W., Abbott, C. A., Park, J. E., Cunningham, A. M., Miller, E., Rettig, W. J., Gorrell, M. D. (https://doi.org/10.1002/hep.510290631>
41. 1994) A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 54, 5702-5710.
, W. L., Lin, C. Y., Aoyama, A., Kelly, T., Akiyama, S. K., Mueller, S. C., Chen, W. T. (
42. 2004) The expression of a type II transmembrane serine protease (seprase) in human gastric carcinoma. Oncology 67, 411-419.
< , Y., Kono, K., Matsumoto, Y., Fujii, H., Yamane, T., Mitsumata, M., Chen, W. T. (https://doi.org/10.1159/000082926>
43. 1999) Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumour stromal fibroblasts. J. Biol. Chem. 274, 36505-36512.
< , J. E., Center, M. C., Zimmermann, R. N., Garin-Chesa, P., Old, L. J., Rettig, W. J. (https://doi.org/10.1074/jbc.274.51.36505>
44. 1989) Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Biochem. J. 262, 327-334.
< , G. A., Callanan, H. M., Mowery, J., Hixson, D. C. (https://doi.org/10.1042/bj2620327>
45. 2004) Fap α, a surface peptidase expressed during wound healing, is a tumor suppressor. Oncogene 23, 5435-5446.
< , T., Blachere, N. E., Sviderskaya, E. V., Bennett D. C., Rettig, W. J., Garin-Chesa, P., Houghton, A. N. (https://doi.org/10.1038/sj.onc.1207730>
46. 1993) Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin. Cancer Res. 53, 3327-3335.
, W. J., Garin-Chesa, P., Healey, J. H., Su, S. L., Ozer, H. L., Schwab, M., Albino, A. P., Old, L. J. (
47. 1994) Molecular cloning of fibroblast activation protein α, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc. Natl. Acad. Sci. USA 91, 5657-5661.
< , M. J., Raj, B. K., Calvo, B., Garin-Chesa, P., SanzMoncasi, M. P., Healey J. H., Old, L. J., Rettig, W. J. (https://doi.org/10.1073/pnas.91.12.5657>
48. 1991) Dipeptidyl peptidase IV in the human lung and spinocellular lung cancer. Physiol. Res. 40, 359-362.
, A., Krepela, E., Kasafirek, E., Kraml, J., Kadlecova, L. (
49. 1996) Cell membranebound proteases: not “only” proteolysis. Physiol. Res. 45, 169-176.
, A., Mandys, V., Krepela, E. (
50. 2008) Dipeptidyl peptidase-IV and related molecules: markers of malignancy? Expert Opin. Med. Diagn. 6, 677-689.
< , A., Stremenova, J, Busek, P., Duke-Cohan, J. S. (https://doi.org/10.1517/17530059.2.6.677>
51. 2004) Structure of a human A-type potassium channel interacting protein DPPX, a member of the dipeptidyl aminopeptidase family. J. Mol. Biol. 343, 1055-1065.
< , P., Bankovich, A. J., Hansen K. C., Garcia K. C., Brunger, A. T. (https://doi.org/10.1016/j.jmb.2004.09.003>
52. 2007) Expression and enzymatic activity of dipeptidyl peptidase-IV in human astrocytic tumours are associated with tumour grade. Int. J. Oncol. 31, 785-792.
, J., Krepela, E., Mares, V., Trim, J., Dbaly, V., Marek, J., Vanickova, Z., Lisa, V., Yea, C., Sedo, A. (
53. 1993) Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol. 150, 2544-2553.
< , M., Gutheil, W. G., Bachovchin, W. W., Huber, B. T. (https://doi.org/10.4049/jimmunol.150.6.2544>
54. 2004) Adenosine downregulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior. Am. J. Pathol. 165, 319-30.
< , E. Y., Mujoomdar, M., Blay, J. (https://doi.org/10.1016/S0002-9440(10)63299-3>
55. 1995) CD26 (dipeptidyl peptidase IV/DPP IV) as a novel molecular marker for differentiated thyroid carcinoma. Int. J. Cancer 64, 326-331.
< , T., Umeki, K., Yamamoto, I., Sakamoto, F., Noguchi, S., Ohtaki, S. (https://doi.org/10.1002/ijc.2910640508>
56. 1995) Proline motifs in peptides and their biological processing. FASEB J. 9, 736-744.
< , G., Goossens, F., De Meester, I., Hendriks, D., Scharpe, S. (https://doi.org/10.1096/fasebj.9.9.7601338>
57. 2004) Crystal structure of CD26/dipeptidylpeptidase IV in complex with adenosine deaminase reveals a highly amphiphilic interface. J. Biol. Chem. 279, 43330-43335.
< , W. A., Liu, J., Reutter, W., Wolfram Saenger, W., Fan, H. (https://doi.org/10.1074/jbc.M405001200>
58. 1999) A role for dipeptidyl peptidase IV in supressing the malignant phenotype of melanocytic cells. J. Exp. Med. 190, 311-322.
< , U. V., Albino, A. P., Tiwari, S., Houghton, A. N. (https://doi.org/10.1084/jem.190.3.311>
59. 2004) Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells. Int. J. Cancer 109, 855-866.
< , U. V., Tiwari, S., Houghton, A. N. (https://doi.org/10.1002/ijc.20091>
60. 2005) Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res. 65, 1325-1334.
< , U. V., McGroarty, M., Homoyouni, A. (https://doi.org/10.1158/0008-5472.CAN-04-1852>
61. 2006) Extraenzymatic functions of the dipeptidyl peptidase IV-related proteins DP8 and DP9 in cell adhesion, migration and apoptosis. FEBS J. 273, 2447-2460.
< , M. T. D., Wang, X. M., McCaughan, G. W., Gorrell, M. D. (https://doi.org/10.1111/j.1742-4658.2006.05253.x>
62. 1998) Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83, 187-195.
< , Z., Karwatowska-Prokopczuk, E., Rose, W., Rone, J., Movafagh, S., Ji, H., Yeh, Y., Chen, W. T., Kleinman, H. K., Grouzmann, E., Grant, D. S. (https://doi.org/10.1161/01.RES.83.2.187>